Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact email@example.com.
SOURCE Research and Markets
DUBLIN, Dec. 17, 2013 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/lvjnqv/cardiac_rhythm) has announced the addition of the "Cardiac Rhythm Management Devices World Markets" report to their offering.
In the last five decades, electronic cardiac medicine has witnessed dramatic technological developments. The cardiac rhythm management products mainly marketed by a handful of global players are used to treat arrhythmias, specifically supraventricular arrhythmias (SVA) and ventricular arrhythmias (VA). The different types of SVA are premature atrial contractions (PAC), supraventricular tachycardia (SVT), sick sinus syndrome (SSS), atrial fibrillation (A-fib) and atrial flutter (AFL). Varying forms of VA are premature ventricular complex (PVC), ventricular tachycardia (VT) and ventricular fibrillation (VF). These cardiac disorders are treated with the aid of different types of electronic cardiac devices.
This report focuses on the global and regional markets for all cardiac rhythm management (CRM) devices, and includes data on implant volumes, procedure costs and reimbursement coverage. This study also covers in detail important areas within CRM such as: implantable cardioverter-defibrillators (ICDs), cardiovascular implantable electronic devices (CIEDs), resynchronisation therapy (CRT), implantable loop recorders (ILRs) and implantable hemodynamic monitoring (IHM).
Key Topics Covered:
2. Cardiac Rhythm Management: An Overview
3. Market Analysis for CRM Products
4. The U.S. and European Scenario of Cardiac Rhythm Management
5. Selected Company Profiles
For more information visit http://www.researchandmarkets.com/research/lvjnqv/cardiac_rhythm
Laura Wood , +353-1-481-1716, firstname.lastname@example.org
©2012 PR Newswire. All Rights Reserved.